Crossref
0542 Enhanced drug safety risk in hyperhidrosis patients taking anticholinergic or antipsychotic medications
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S94
DOI: 10.1016/j.jid.2026.06.573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von S. Kapur und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kapur, S., Houdi, M., Nguyen, K., Sidhu, K., Bazzi, M., & Burkhart, C. (2026). 0542 Enhanced drug safety risk in hyperhidrosis patients taking anticholinergic or antipsychotic medications. Journal of Investigative Dermatology, 146(8), S94. https://doi.org/10.1016/j.jid.2026.06.573
Vancouver
Kapur S, Houdi M, Nguyen K, Sidhu K, Bazzi M, Burkhart C. 0542 Enhanced drug safety risk in hyperhidrosis patients taking anticholinergic or antipsychotic medications. Journal of Investigative Dermatology. 2026;146(8):S94. doi:10.1016/j.jid.2026.06.573
BibTeX
@article{Kapur2026,
author = {Kapur, S. and Houdi, M.A. and Nguyen, K. and Sidhu, K.S. and Bazzi, M. and Burkhart, C.},
title = {0542 Enhanced drug safety risk in hyperhidrosis patients taking anticholinergic or antipsychotic medications},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S94},
doi = {10.1016/j.jid.2026.06.573}
}
EUVIMED